An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease

על הניסוי

The primary objective of this study is to evaluate the safety and tolerability of the long-term use of TPIP in participants with PH-ILD from Study INS1009-311 (NCT07179380).

צפו ב-NCT07234032 ב-ClinicalTrials.gov ←

קישורים קשורים

ניסויים קשורים